Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-phase-1-clinical-trial-centre-celebrates-10th-anniversary-centre-has-completed-150-early-stage-studies-of-novel-drugs-for-cancer-diabetes-and-more
https://www.med.cuhk.edu.hk/press-releases/cuhk-phase-1-clinical-trial-centre-celebrates-10th-anniversary-centre-has-completed-150-early-stage-studies-of-novel-drugs-for-cancer-diabetes-and-more

CUHK Phase 1 Clinical Trial Centre celebrates 10th anniversary Centre has completed 150 early-stage studies of novel drugs for cancer, diabetes and more

The Chinese University of Hong Kong (CUHK)’s Phase 1 Clinical Trial Centre (CUHK P1CTC) is  celebrating its 10th anniversary. Over the past 10 years, CUHK P1CTC, with its state-of-the-art facilities, has completed 150 early-stage studies of novel drugs for cancer, diabetes, liver diseases, heart diseases and more, contributing to the drug registration process in Europe, the US and mainland China. Furthermore, the CUHK team has built a healthy volunteer database of over 8,000 people, which provides a solid foundation for clinical research in Hong Kong. 

 

P1CTC 10th anniversary

CUHK Phase 1 Clinical Trial Centre (P1CTC) celebrates 10th  anniversary. Over the past decade, CUHK P1CTC has completed over 150 early-stage studies of novel drugs for cancer, diabetes, liver, heart diseases, and more. The team has as well built a healthy volunteer database of more than 8,000 people, providing a solid foundation for clinical trial in Hong Kong. (From right) Chief Director Professor Anthony Chan, Medical Director (Oncology) Professor Bridget Ma, study participants Mrs Chan and Mr Lee, Deputy Medical Director (Non-Oncology) Dr Elaine Chow and Medical Director (Non-Oncology) Professor Andrea Luk of CUHK P1CTC.  

Early-stage clinical study data submitted to authorities worldwide

 

New medications are developed through clinical research. CUHK was the first institution in Hong Kong to conduct phase 1 clinical trials, which involve administering new medications to human beings for the first time after extensive laboratory testing, primarily to assess their safety and tolerability. With support from the government, CUHK established P1CTC in 2013 as a driving force for innovative medical research and a resource in the search for novel therapeutic solutions that suit Chinese and other Asian communities.

 

Professor Anthony Chan, Chief Director of CUHK P1CTC and Li Shu Fan Medical Foundation Professor of Clinical Oncology at CU Medicine, remarked, “CUHK is fully committed and ready to conduct clinical trials with the aim of providing innovative therapies to patients. Our Centre is at the forefront of clinical research with first-in-human studies and was accredited by the National Medical Products Administration (NMPA) in 2016, meaning the clinical study data generated there will be accepted by regulatory authorities in mainland China for registration purposes. Our data have also been submitted to the US, European and Japanese regulatory authorities.”

 

Clinical cancer trials give patients hope

 

Cancer constitutes 40% of the Centre’s clinical trials, with the others including liver disease, heart disease and diabetes. The CU Medicine clinical oncology team’s work has resulted in novel drugs being developed for lung, nasopharyngeal and liver cancers.    

 

Professor Brigette Ma, Medical Director (Oncology) of CUHK P1CTC and Professor in the Department of Clinical Oncology at CU Medicine, said, “Some cancer patients develop resistance to treatment after a period, so we need to explore new therapeutic options. Clinical research is not without risk, but it often provides late-stage or treatment-lacking patients with a ray of hope for survival. We have a very experienced team dedicated to helping patients navigate through the tough times.”  

 

CUHK team helped confirm new diabetes treatment
 

CUHK P1CTC’s diabetes team is expert in evaluating novel drugs and devices to treat the disease. For instance, the team demonstrated that first-in-class glucokinase activator dorzagliatin can restore abnormal pancreatic glucose sensing in people with diabetes. This drug was approved by the China NMPA in 2022 as a new diabetes treatment option.

 

Dr Elaine Chow, Deputy Medical Director (Non-Oncology) of CUHK P1CTC and Assistant Professor in the Department of Medicine and Therapeutics at CU Medicine, said, “P1CTC collaborates closely with overseas and local startups to develop new medications and devices that can transform patient care.” 

 

Mrs Chan

Mrs Chan was diagnosed with advanced triple negative breast cancer in 2017. Unfortunately, cancer came back after treatment and the tumour kept growing. She was subsequently referred to participate in novel immunotherapy study at CUHK P1CTC. Her cancer was successfully under control after three years of trial. Mrs Chan said her biggest dream had been to see her sons getting married and having children. Now she has had her dream come true thanks to the clinical trial.      

Mr Lee

Mr Lee has been suffering from Type 1 diabetes for more than 30 years and has to closely monitor his blood sugar level every day. He has joined two CUHK’s clinical trials over the past decade, including a new insulin treatment option and a new blood sugar monitoring device. He was happy to try out the two innovations which did make his life easier and relief his stress over blood sugar monitoring and managing. He hopes his contribution as a clinical trial  subject could help bring in more treatment options for other diabetes patients.

Healthy volunteers are indispensable for early-stage clinical trial success

 

Recruiting healthy volunteers is essential for early-stage clinical studies. Currently over 8,000 people have joined the Centre’s healthy volunteer scheme by registering online. As of today, 2,500 of them have participated in over 40 studies.

 

Professor Andrea Luk, Medical Director (Non-Oncology) of CUHK P1CTC and Professor in the Department of Medicine and Therapeutics at CU Medicine, said, “We are deeply grateful for the support of the numerous healthy volunteers who have participated in clinical research, offering new treatment prospects for patients in need. As the general public gains more exposure and understanding of medical research, we hope to see more people become volunteers and help initiate more early-stage clinical studies.” 

 

Professor Chan concluded, “Hong Kong is at the forefront of medical research, with world-class teams conducting basic and clinical research. Chinese medicine and biotechnology are the two areas we have started to explore, including evaluating drug delivery systems and devices for Chinese medicine and facilitating the clinical translation of scientific discoveries in biotechnology and life science inventions. We will continue our efforts to enrich the local research ecosystem and heighten Hong Kong’s exposure to the best medical innovation.”

 

P1CTC introduction

CUHK P1CTC is equipped with four cubicles, 24 beds in total, dedicated for overnight observations. The Centre also has its own laboratory, drug storage & specimen processing facilities and advanced therapy products storage for research purpose.

More Press Releases

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK Opens Phase I Clinical Trial Centre To Step Up New Drug Development in Hong Kong

CUHK Opens Phase I Clinical Trial Centre To Step Up New Drug Development in Hong Kong

Research
CUHK develops an accurate machine learning model that uses big data to predict the risk of severe hypoglycemia in the next 12 months among older adults with diabetes

CUHK develops an accurate machine learning model that uses big data to predict the risk of severe hypoglycemia in the next 12 months among older adults with diabetes

Research
CUHK study shows few patients with type 2 diabetes can achieve diabetes  remission in real-world settings through weight loss at early stage and eventually stop medications

CUHK study shows few patients with type 2 diabetes can achieve diabetes remission in real-world settings through weight loss at early stage and eventually stop medications

Research
Professor Anthony Chan honoured with the ESMO Lifetime Achievement Award  Global recognition for his leadership and outstanding research in nasopharyngeal cancer

Professor Anthony Chan honoured with the ESMO Lifetime Achievement Award Global recognition for his leadership and outstanding research in nasopharyngeal cancer

Awards and honors
CUHK identifies a new genetic marker to predict heart disease risk in people with diabetes Study finding highlights the potential of precision medicine in diabetes

CUHK identifies a new genetic marker to predict heart disease risk in people with diabetes Study finding highlights the potential of precision medicine in diabetes

Research
New initiative launched to support and empower young people with diabetes

New initiative launched to support and empower young people with diabetes

Health Campaign
CUHK study shows prediabetes in young people predicts a 90% lifetime risk of diabetes and is linked to nearly 70% higher risks of cardiovascular diseases

CUHK study shows prediabetes in young people predicts a 90% lifetime risk of diabetes and is linked to nearly 70% higher risks of cardiovascular diseases

Research
CUHK study supports continuation of renin-angiotensin system inhibitors (RASi) in patients with type 2 diabetes and advanced chronic kidney disease to reduce major cardiorenal complications

CUHK study supports continuation of renin-angiotensin system inhibitors (RASi) in patients with type 2 diabetes and advanced chronic kidney disease to reduce major cardiorenal complications

Research
CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

Research
CU Medicine Studies Reveal Diabetes Death and Complication Rates Declining - but Not in the Young

CU Medicine Studies Reveal Diabetes Death and Complication Rates Declining - but Not in the Young

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
CUHK Study Reveals 1 in 6 Diabetic Patients Project Rapid Renal Function Decline

CUHK Study Reveals 1 in 6 Diabetic Patients Project Rapid Renal Function Decline

Research
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
CUHK Research Reveals Young People with Normal Body Weight May Also Suffer from Diabetes Timely Treatment within 5-Year Golden Period may Help Prevent Complications

CUHK Research Reveals Young People with Normal Body Weight May Also Suffer from Diabetes Timely Treatment within 5-Year Golden Period may Help Prevent Complications

Research
CU Medicine developed an innovative mRNA drug for treatment of nasopharyngeal carcinoma

CU Medicine developed an innovative mRNA drug for treatment of nasopharyngeal carcinoma

Research
A CU-led international study identifies metabolomic markers for diabetic kidney disease and cardiovascular disease in patients with type 2 diabetes

A CU-led international study identifies metabolomic markers for diabetic kidney disease and cardiovascular disease in patients with type 2 diabetes

Research
CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

Research
A major international study identifies biomarkers that enhance prediction accuracy of cardiovascular diseases in people with diabetes and have potential to change clinical practice

A major international study identifies biomarkers that enhance prediction accuracy of cardiovascular diseases in people with diabetes and have potential to change clinical practice

Research
CUHK study finds rising laryngeal cancer rates among women in some locations, despite global decline

CUHK study finds rising laryngeal cancer rates among women in some locations, despite global decline

Research
CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

Research
CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

Research
CUHK proves the eHealth App’s Health Management module helps promote  self-management of diabetes

CUHK proves the eHealth App’s Health Management module helps promote self-management of diabetes

Research
CUHK’s study sees small intestinal cancer incidence rising globally and in Hong Kong Higher incidence observed in high-income countries

CUHK’s study sees small intestinal cancer incidence rising globally and in Hong Kong Higher incidence observed in high-income countries

Research
CUHK study sees a rising trend in primary brain cancer incidence in younger males in high-income countries

CUHK study sees a rising trend in primary brain cancer incidence in younger males in high-income countries

Research
CUHK survey finds half of pregnant women have excessive sodium intake during early pregnancy

CUHK survey finds half of pregnant women have excessive sodium intake during early pregnancy

Research
CUHK unlocks the secret of cancer pain  Identifying a new therapeutic key to ending the sorrow

CUHK unlocks the secret of cancer pain Identifying a new therapeutic key to ending the sorrow

Research
CUHK’s study sees a rising trend of multiple myeloma incidence,  particularly in older males from high-income countries

CUHK’s study sees a rising trend of multiple myeloma incidence, particularly in older males from high-income countries

Research
CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

Donation
CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

Research
International study led by CU Medicine highlights significant global incidence of newly diagnosed type 1 diabetes among adults much higher than previously believed

International study led by CU Medicine highlights significant global incidence of newly diagnosed type 1 diabetes among adults much higher than previously believed

Research
CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

Research
CUHK study shows DNA telomere length can predict the decline in kidney function in diabetes patients

CUHK study shows DNA telomere length can predict the decline in kidney function in diabetes patients

Research
CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

Research
CU Medicine Professor Ronald Ma Receives Prestigious Research Award from  The Asian Association for The Study of Diabetes

CU Medicine Professor Ronald Ma Receives Prestigious Research Award from The Asian Association for The Study of Diabetes

Awards and honors
CUHK Study Shows Regular Exercise Is a Safe Diabetes Prevention Strategy For People Living in Polluted Regions

CUHK Study Shows Regular Exercise Is a Safe Diabetes Prevention Strategy For People Living in Polluted Regions

Research
CU Medicine Researchers Discover Shortened DNA Telomere Length as a Useful Biomarker to Identify Patients with Diabetes at High Risk of Cardiovascular Disease

CU Medicine Researchers Discover Shortened DNA Telomere Length as a Useful Biomarker to Identify Patients with Diabetes at High Risk of Cardiovascular Disease

Research
Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

Research
CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Research
CUHK Medicine Professor Juliana Chan Receives International Honour for  Outstanding Research and Care in Diabetes

CUHK Medicine Professor Juliana Chan Receives International Honour for Outstanding Research and Care in Diabetes

Awards and honors
CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

Donation
Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
CUHK Receives an International Cancer Care Team Award Nominated by Patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

Awards and honors
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

Surgical advancement
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

Research
CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

Research
CUHK Study Reveals Peer Support Can Reduce Hospital Admission of Distressed Diabetes Patients

CUHK Study Reveals Peer Support Can Reduce Hospital Admission of Distressed Diabetes Patients

Research
Risk of Diabetes Patients Having Depression Doubles That of the General Public CUHK Advocates Timely Assessment of Diabetes Patients’ Mental Health Conditions

Risk of Diabetes Patients Having Depression Doubles That of the General Public CUHK Advocates Timely Assessment of Diabetes Patients’ Mental Health Conditions

Research
The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

Symposium
CUHK Advocates New Approach for Diabetes Care

CUHK Advocates New Approach for Diabetes Care

Research
CUHK Research Explains Why Patients with Cystic Fibrosis Often Develop Diabetes

CUHK Research Explains Why Patients with Cystic Fibrosis Often Develop Diabetes

Research
CUHK Research Shows 60% Diabetic Patients Have Poor Sleep Auriculotherapy Helps Improve Sleep Quality and Glycaemic Control

CUHK Research Shows 60% Diabetic Patients Have Poor Sleep Auriculotherapy Helps Improve Sleep Quality and Glycaemic Control

Research
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK and Shanghai Jiao Tong University Discover Genetic Predictor of Diabetes in Chinese Patients

CUHK and Shanghai Jiao Tong University Discover Genetic Predictor of Diabetes in Chinese Patients

Research
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research
CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

Symposium
CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

Surgical advancement
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
CUHK Develops an Automatic Retinal Image Analysis System to Help Diabetes Patients and Elderly Prevent Stroke

CUHK Develops an Automatic Retinal Image Analysis System to Help Diabetes Patients and Elderly Prevent Stroke

Research
The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

Symposium
Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Clinical service

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.